MakScientific LLC
http://www.makscientific.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From MakScientific LLC
Deals In Depth: March 2012
Glaxo sold a European portfolio of non-core OTC products to Omega Pharma for $614 million. Device companies Zoll Medical and Cameron Health were acquired in two separate billion-dollar-plus deals. Biopharma funding reached $1 billion and device firms raised $539 million.
Deals Shaping The Medical Industry, April 2012
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Deals Of The Week: Merck/Calibr, GSK/Epistem, Biogen Idec/MAKScientific
Shire addresses its Replagal disappointment with the acquisition of FerroKin and its hematology pipeline.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice